United Therapeutics Corporation (UTHR) Net margin 2016–2025
United Therapeutics Corporation (UTHR) net profit margin by fiscal year — reported net income divided by reported revenue.
41.9%FY2025 · since FY2016: 44.6% → 41.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 41.9% | +0.4 pp |
| FY2024 | 41.5% | -0.8 pp |
| FY2023 | 42.3% | +4.8 pp |
| FY2022 | 37.6% | +9.3 pp |
| FY2021 | 28.2% | -6.5 pp |
| FY2020 | 34.7% | +41.9 pp |
| FY2019 | -7.2% | -43.4 pp |
| FY2018 | 36.2% | +12.0 pp |
| FY2017 | 24.2% | -20.4 pp |
| FY2016 | 44.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice